van Wezel T - Search Results

1

Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib.

Lee CJ, Schöffski P, Modave E, van Wezel T, Boeckx B, Sufliarsky J, Gelderblom H, Blay JY, Debiec-Rychter M, Sciot R, Bovée JVMG, Lambrechts D, Wozniak A. Lee CJ, et al. Among authors: van wezel t. Clin Cancer Res. 2021 Dec 15;27(24):6737-6748. doi: 10.1158/1078-0432.CCR-21-1165. Epub 2021 Sep 22. Clin Cancer Res. 2021. PMID: 34551905

2

cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade.

Rozeman LB, Hameetman L, van Wezel T, Taminiau AH, Cleton-Jansen AM, Hogendoorn PC, Bovée JV. Rozeman LB, et al. Among authors: van wezel t. J Pathol. 2005 Sep;207(1):61-71. doi: 10.1002/path.1813. J Pathol. 2005. PMID: 16007578

3

Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue.

van Puijenbroek M, Nielsen M, Tops CM, Halfwerk H, Vasen HF, Weiss MM, van Wezel T, Hes FJ, Morreau H. van Puijenbroek M, et al. Among authors: van wezel t. Clin Cancer Res. 2008 Jan 1;14(1):139-42. doi: 10.1158/1078-0432.CCR-07-1705. Clin Cancer Res. 2008. PMID: 18172263

4

Progression and tumor heterogeneity analysis in early rectal cancer.

Lips EH, van Eijk R, de Graaf EJ, Doornebosch PG, de Miranda NF, Oosting J, Karsten T, Eilers PH, Tollenaar RA, van Wezel T, Morreau H. Lips EH, et al. Among authors: van eijk r, van wezel t. Clin Cancer Res. 2008 Feb 1;14(3):772-81. doi: 10.1158/1078-0432.CCR-07-2052. Clin Cancer Res. 2008. PMID: 18245538

5

Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatment.

Schrage YM, Briaire-de Bruijn IH, de Miranda NF, van Oosterwijk J, Taminiau AH, van Wezel T, Hogendoorn PC, Bovée JV. Schrage YM, et al. Among authors: van wezel t, van oosterwijk j. Cancer Res. 2009 Aug 1;69(15):6216-22. doi: 10.1158/0008-5472.CAN-08-4801. Epub 2009 Jul 14. Cancer Res. 2009. PMID: 19602594

6

Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.

Pansuriya TC, van Eijk R, d'Adamo P, van Ruler MA, Kuijjer ML, Oosting J, Cleton-Jansen AM, van Oosterwijk JG, Verbeke SL, Meijer D, van Wezel T, Nord KH, Sangiorgi L, Toker B, Liegl-Atzwanger B, San-Julian M, Sciot R, Limaye N, Kindblom LG, Daugaard S, Godfraind C, Boon LM, Vikkula M, Kurek KC, Szuhai K, French PJ, Bovée JV. Pansuriya TC, et al. Among authors: van oosterwijk jg, van eijk r, van wezel t, van ruler ma. Nat Genet. 2011 Nov 6;43(12):1256-61. doi: 10.1038/ng.1004. Nat Genet. 2011. PMID: 22057234 Free PMC article.

7

Infiltration of Lynch colorectal cancers by activated immune cells associates with early staging of the primary tumor and absence of lymph node metastases.

de Miranda NF, Goudkade D, Jordanova ES, Tops CM, Hes FJ, Vasen HF, van Wezel T, Morreau H. de Miranda NF, et al. Among authors: van wezel t. Clin Cancer Res. 2012 Mar 1;18(5):1237-45. doi: 10.1158/1078-0432.CCR-11-1997. Epub 2012 Jan 18. Clin Cancer Res. 2012. PMID: 22261803

8

Mutational analyses of epidermal growth factor receptor and downstream pathways in adrenocortical carcinoma.

Hermsen IG, Haak HR, de Krijger RR, Kerkhofs TM, Feelders RA, de Herder WW, Wilmink H, Smit JW, Gelderblom H, de Miranda NF, van Eijk R, van Wezel T, Morreau H. Hermsen IG, et al. Among authors: van eijk r, van wezel t. Eur J Endocrinol. 2013 Jun 1;169(1):51-8. doi: 10.1530/EJE-13-0093. Print 2013 Jul. Eur J Endocrinol. 2013. PMID: 23585556

9

Functional profiling of receptor tyrosine kinases and downstream signaling in human chondrosarcomas identifies pathways for rational targeted therapy.

Zhang YX, van Oosterwijk JG, Sicinska E, Moss S, Remillard SP, van Wezel T, Bühnemann C, Hassan AB, Demetri GD, Bovée JV, Wagner AJ. Zhang YX, et al. Among authors: van oosterwijk jg, van wezel t. Clin Cancer Res. 2013 Jul 15;19(14):3796-807. doi: 10.1158/1078-0432.CCR-12-3647. Epub 2013 May 28. Clin Cancer Res. 2013. PMID: 23714727

10

Safety and efficacy of the addition of simvastatin to panitumumab in previously treated KRAS mutant metastatic colorectal cancer patients.

Baas JM, Krens LL, Bos MM, Portielje JE, Batman E, van Wezel T, Morreau H, Guchelaar HJ, Gelderblom H. Baas JM, et al. Among authors: van wezel t. Anticancer Drugs. 2015 Sep;26(8):872-7. doi: 10.1097/CAD.0000000000000255. Anticancer Drugs. 2015. PMID: 26053280 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page